Company / Profit Margin
Imunon, Inc. Profit Margin History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-7179.6%
FY2023
5-year range
-7179.6% / -2376.7%
FY2019-FY2023
Trend
-72.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 7 years, ranging from -7179.6% in FY2023 to -2376.7% in FY2019.
Based on SEC 10-K filings.
-7179.6% in FY2023 with a 5-year CAGR of -3099.2%.
Declined from -4296.7% to -7179.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -3809.3pp
- 5-Year Change
- -3099.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, profit margin decreased 72.8% year-over-year.
- Peak profit margin was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -7179.6% | -72.8% |
| FY2022 | -4153.9% | +3.3% |
| FY2021 | -4296.7% | -27.5% |
| FY2020 | -3370.3% | -41.8% |
| FY2019 | -2376.7% | +41.8% |
| FY2018 | -4080.4% | +38.2% |
| FY2015 | -6601.1% | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026